Periodic Reporting for period 2 - CLEAN SLATE (LightSense's Breakthrough medical device for aesthetic healthcare)
Berichtszeitraum: 2020-06-15 bis 2021-06-14
LightSense has developed and patented a breakthrough technology that dramatically improves non-invasive dermatological healthcare.
We have brought this technology to market through our first clinic in London and our ambition is to rollout clinics globally.
We offer aesthetic dermatology services focused on exogenous and endogenous pigments because (1) there is large and growing market, over 100 million people are looking for a solution; (2) current treatment offerings are ineffective, painful, damaging to skin tissue, and very lengthy; (3) our technology breakthrough positions us to offer a significantly better treatment experience.
With success in treating pigmentation disorders, we intend to expand our offering, establishing industry-wide and academically recognised solutions for many laser dermatology procedures. This project focused on finalising product development and testing, gaining regulatory approval through clinical studies, and final commercialisation of the innovation - all of which were successfully achieved.
We have brought this technology to market through our first clinic in London and our ambition is to rollout clinics globally.
We offer aesthetic dermatology services focused on exogenous and endogenous pigments because (1) there is large and growing market, over 100 million people are looking for a solution; (2) current treatment offerings are ineffective, painful, damaging to skin tissue, and very lengthy; (3) our technology breakthrough positions us to offer a significantly better treatment experience.
With success in treating pigmentation disorders, we intend to expand our offering, establishing industry-wide and academically recognised solutions for many laser dermatology procedures. This project focused on finalising product development and testing, gaining regulatory approval through clinical studies, and final commercialisation of the innovation - all of which were successfully achieved.
During the final period of the project, we successfully completed all project objectives successfully.
We took significant steps towards the achievement of project objectives during the first reporting period.
We conducted a successful clinical study. In summary, the clinical study approved and validated the safety and efficacy of LightSense’s technology. Both primary and secondary study end points were met successfully.
We finalised product design and development of the commercial system. We worked closely with an independent laboratory to conduct IEC 60601 testing. We obtained IEC 60601 approval and thereafter submitted our system for CE Medical Certification. We obtained our CE Certification in May 2020.
The CE certification was crucial to commercial launch. Therefore, we were able to bring forward our efforts in launching the first pilot clinic. Although we did not launch the clinic during the first reporting period, we were able to undertake meaningful preparation, including securing, designing, and renovating a space as well as commencing hiring and training of clinic staff.
We created brand assets, including selecting our name and logo, and launched our website. We established a social media presence and posted quality proprietary content. We initiated various marketing channels in anticipation of the pilot clinic launch, including social media, paid social, tattoo artist referrals and word of mouth campaigns.
Prior to launch of the clinic, we completed staff training and assessments including both technical and overall customer experience. Since we launched during Covid, we set up stricter than mandated Covid guidelines and we are grateful to the clinic team for their strict adherence, acknowledging that it makes their jobs a little harder. We completed clinic pre-launch preparation, including sourcing and ordering treatment, Covid and general consumables.
The culmination of commercialisation journey of many years was completed with the opening of our pilot clinic in Central London in July 2020. LightSense was founded to commercialise and bring to market breakthrough technology from Princeton University, and this is what we achieved with the successful launch of our clinic. Our focus for the launch month was safety & the best interests of our clients, learning from a live operating environment, confirming laser parameters, and understanding what is important to our clients.
We took significant steps towards the achievement of project objectives during the first reporting period.
We conducted a successful clinical study. In summary, the clinical study approved and validated the safety and efficacy of LightSense’s technology. Both primary and secondary study end points were met successfully.
We finalised product design and development of the commercial system. We worked closely with an independent laboratory to conduct IEC 60601 testing. We obtained IEC 60601 approval and thereafter submitted our system for CE Medical Certification. We obtained our CE Certification in May 2020.
The CE certification was crucial to commercial launch. Therefore, we were able to bring forward our efforts in launching the first pilot clinic. Although we did not launch the clinic during the first reporting period, we were able to undertake meaningful preparation, including securing, designing, and renovating a space as well as commencing hiring and training of clinic staff.
We created brand assets, including selecting our name and logo, and launched our website. We established a social media presence and posted quality proprietary content. We initiated various marketing channels in anticipation of the pilot clinic launch, including social media, paid social, tattoo artist referrals and word of mouth campaigns.
Prior to launch of the clinic, we completed staff training and assessments including both technical and overall customer experience. Since we launched during Covid, we set up stricter than mandated Covid guidelines and we are grateful to the clinic team for their strict adherence, acknowledging that it makes their jobs a little harder. We completed clinic pre-launch preparation, including sourcing and ordering treatment, Covid and general consumables.
The culmination of commercialisation journey of many years was completed with the opening of our pilot clinic in Central London in July 2020. LightSense was founded to commercialise and bring to market breakthrough technology from Princeton University, and this is what we achieved with the successful launch of our clinic. Our focus for the launch month was safety & the best interests of our clients, learning from a live operating environment, confirming laser parameters, and understanding what is important to our clients.
Our focus for the final year of the project was commercial launch and validation. We launched our pilot clinic in London in July 2020. The results have been encouraging as evidenced by our client retention rate in excess of our target and the incredible customers reviews we have received.
We will undertake continuous improvement of our technology to ensure treatment efficacy and manufacturability of our system in anticipation of scaling.
We believe this treatment can empower people to start new beginnings. In the United Kingdom, we have developed a charity program whereby we provide free service to select members of marginalised communities in attempt to democratise access to cutting edge healthcare technology. We have treated numerous people from the Forward Trust (an organisation empowering people to break the often interlinked cycles of crime and addiction) and other charities.
As we scale the business, it is our goal to maximise the impact of these types of programs and replicate them in every city where we launch.
We will undertake continuous improvement of our technology to ensure treatment efficacy and manufacturability of our system in anticipation of scaling.
We believe this treatment can empower people to start new beginnings. In the United Kingdom, we have developed a charity program whereby we provide free service to select members of marginalised communities in attempt to democratise access to cutting edge healthcare technology. We have treated numerous people from the Forward Trust (an organisation empowering people to break the often interlinked cycles of crime and addiction) and other charities.
As we scale the business, it is our goal to maximise the impact of these types of programs and replicate them in every city where we launch.